Page last updated: 2024-09-03

inositol cyclic phosphate and Diabetes Mellitus, Type 2

inositol cyclic phosphate has been researched along with Diabetes Mellitus, Type 2 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bao, Y; Broomfield, SJ; Galasko, GT; Hooper, NM; Larner, J; Turner, AJ	1

Other Studies

1 other study(ies) available for inositol cyclic phosphate and Diabetes Mellitus, Type 2

Article	Year
Circulating factors and insulin resistance. I. A novel myoinositol 1,2-cyclic phosphate phosphoglycan insulin antagonist from human plasma is elevated in noninsulin-dependent diabetes mellitus. The Journal of clinical endocrinology and metabolism, 1995, Volume: 80, Issue:8 Topics: Adipocytes; Adult; Animals; Chromatography, Gel; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Inositol; Inositol Phosphates; Insulin; Insulin Antagonists; Insulin Resistance; Lipids; Male; Middle Aged; Monosaccharides; Polysaccharides; Rats; Reference Values	1995

Article

Year

Circulating factors and insulin resistance. I. A novel myoinositol 1,2-cyclic phosphate phosphoglycan insulin antagonist from human plasma is elevated in noninsulin-dependent diabetes mellitus.

The Journal of clinical endocrinology and metabolism, 1995, Volume: 80, Issue:8

Topics: Adipocytes; Adult; Animals; Chromatography, Gel; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Inositol; Inositol Phosphates; Insulin; Insulin Antagonists; Insulin Resistance; Lipids; Male; Middle Aged; Monosaccharides; Polysaccharides; Rats; Reference Values

1995